Medicare Enrolled

Dr. Farid Azizollahi, MD

Family Medicine · Beverly Hills, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
8920 WILSHIRE BLVD STE 335, Beverly Hills, CA 90211
3104218835
In practice since 2007 (19 years)
NPI: 1649328519 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Azizollahi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Azizollahi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Azizollahi

Dr. Farid Azizollahi is a family medicine specialist in Beverly Hills, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Azizollahi performed 4,774 Medicare services across 2,345 unique beneficiaries.

Between the years covered by Open Payments, Dr. Azizollahi received a total of $8,068 from 55 pharmaceutical and/or device companies across 397 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Azizollahi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 3% volume in CA $8,068 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,774
Medicare services
Top 3% in CA for family medicine
2,345
Unique beneficiaries
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~251 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
978 $79 $150
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
500 $13 $50
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
435 $1 $35
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
397 $111 $201
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
396 $8 $30
Nursing facility visit, high complexity
A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves a high level of medical decision making and takes at least 45 minutes.
396 $133 $300
Home health agency supervision, complex multidisciplinary care
Supervision by a physician or allowed practitioner for a patient receiving Medicare-covered services from a participating home health agency. This involves complex and multidisciplinary care modalities, with the patient not present during the supervision.
291 $91 $150
Home visit, established patient, moderate complexity
A home visit for an established patient involving moderate medical decision making. The visit requires at least 40 minutes of time if time is used to determine the level of service.
187 $110 $250
Home health plan of care re-certification
A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present.
171 $37 $100
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
131 $69 $150
Home health plan of care certification
Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians.
123 $46 $100
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
120 $102 $200
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
86 $50 $65
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
84 $144 $400
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
63 $13 $75
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
56 $150 $400
Hospital discharge management, 30+ min
This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge.
53 $100 $150
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
46 $154 $300
COVID-19 amplified DNA/RNA probe detection
A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen.
41 $50 $250
Echocardiogram, transthoracic
An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function.
35 $157 $600
Initial nursing facility care, high complexity
An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes.
33 $157 $330
Ultrasound of head and neck blood flow, bilateral
An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck.
28 $167 $400
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
26 $141 $300
Ketorolac injection, per 15 mg
An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg.
24 $0 $25
Ear wax removal
A procedure to remove impacted ear wax from the ear canal.
22 $41 $101
Home visit, established patient, low complexity
A physician visits an existing patient at their residence to provide care involving a low level of medical decision making. The visit lasts at least 30 minutes.
22 $66 $200
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
18 $27 $36
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
12 $91 $150
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.7% high complexity
20.7% medium
78.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$8,068
Total received (2018-2024)
Avg $1,153/year across 7 years
Top 5% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
397
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,821 (96.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$247 (3.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,676
2023
$1,585
2022
$1,584
2021
$714
2020
$313
2019
$1,170
2018
$1,026

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$222
AstraZeneca Pharmaceuticals LP
$197
Boehringer Ingelheim Pharmaceuticals, Inc.
$151
Ardelyx, Inc.
$133
Amgen Inc.
$131
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$106
Phathom Pharmaceuticals, Inc.
$99
Lilly USA, LLC
$94
Janssen Pharmaceuticals, Inc
$84
Bayer Healthcare Pharmaceuticals Inc.
$77
AIMMUNE THERAPEUTICS, INC.
$71
Otsuka America Pharmaceutical, Inc.
$50
Exact Sciences Corporation
$50
Radius Health, Inc.
$42
PFIZER INC.
$38
SHIELD THERAPEUTICS INC
$30
Corcept Therapeutics
$25
Merck Sharp & Dohme LLC
$24
Abbott Laboratories
$18
IRONWOOD PHARMACEUTICALS, INC
$17
Novo Nordisk Inc
$17
Top 3 companies account for 34.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$761
Amgen Inc.
$642
Janssen Pharmaceuticals, Inc
$622
ABBVIE INC.
$455
Lilly USA, LLC
$447
AbbVie Inc.
$407
Boehringer Ingelheim Pharmaceuticals, Inc.
$405
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$379
Astellas Pharma US Inc
$378
Amarin Pharma Inc.
$314
PFIZER INC.
$290
AbbVie, Inc.
$182
Bayer Healthcare Pharmaceuticals Inc.
$182
Allergan Inc.
$176
Bayer HealthCare Pharmaceuticals Inc.
$161
Novo Nordisk Inc
$136
Novartis Pharmaceuticals Corporation
$135
Ardelyx, Inc.
$133
Merck Sharp & Dohme Corporation
$117
Takeda Pharmaceuticals U.S.A., Inc.
$113
Otsuka America Pharmaceutical, Inc.
$104
Radius Health, Inc.
$104
AIMMUNE THERAPEUTICS, INC.
$101
Phathom Pharmaceuticals, Inc.
$99
Nestle HealthCare Nutrition Inc.
$90
Exact Sciences Corporation
$89
E.R. Squibb & Sons, L.L.C.
$76
Sumitomo Pharma America, Inc.
$75
Ironwood Pharmaceuticals, Inc
$74
NESTLE HEALTHCARE NUTRITION INC.
$66
GlaxoSmithKline, LLC.
$58
Allergan, Inc.
$52
Synergy Pharmaceuticals Inc
$49
Horizon Therapeutics plc
$47
Biohaven Pharmaceutical Holding Company Ltd.
$47
ARBOR PHARMACEUTICALS, INC.
$46
Endo Pharmaceuticals Inc.
$38
Kowa Pharmaceuticals America, Inc.
$37
Almatica Pharma LLC
$32
Scilex Pharmaceuticals Inc.
$31
SHIELD THERAPEUTICS INC
$30
Axsome Therapeutics, Inc.
$28
GENZYME CORPORATION
$27
Corcept Therapeutics
$25
Merck Sharp & Dohme LLC
$24
Biogen, Inc.
$24
Lexicon Pharmaceuticals, Inc.
$23
Lundbeck LLC
$21
Corium, LLC
$19
Abbott Laboratories
$18
Shield Therapeutics Inc
$18
IRONWOOD PHARMACEUTICALS, INC
$17
EISAI INC.
$17
SUN PHARMACEUTICAL INDUSTRIES INC.
$16
Medicure Pharma Inc.
$13
Top 3 companies account for 25.1% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADUHELM · AIRSUPRA · Adlarity · Aduhelm · Aimovig · Auvelity · BAQSIMI · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BREZTRI · BRILINTA · BYDUREON · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · CREON · Cologuard Collection Kit · Creon · DIFICID · DUPIXENT · ELIQUIS · EMGALITY · ENTRESTO · ETERNA · EVENITY · Edarbi · Edarbyclor · FARXIGA · FORTEO · GEMTESA · GRALISE · IBSRELA · INVOKANA · Inpefa · JANUVIA · JARDIANCE · KAPSPARGO · Kerendia · Korlym · LINZESS · LOKELMA · Linzess · Livalo · MOUNJARO · MYRBETRIQ · Motegrity · Myrbetriq · NAMZARIC · NASCOBAL · NURTEC ODT · Otezla · Ozempic · PAXLOVID · PENNSAID · PREVNAR 13 · Prolia · QULIPTA · REXULTI · Repatha · Rybelsus · SEGLENTIS · SPIRIVA · SPIRIVA RESPIMAT · SPRAVATO · SYMBICORT · SYNTHROID · TEPEZZA · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Trintellix · Trulance · Tymlos · UBRELVY · VIBERZI · VOQUEZNA · VOWST · VRAYLAR · Vascepa · XARELTO · XIFAXAN · ZENPEP · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · ZYPITAMAG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for family medicine in CA.

Looking for a family medicine specialist in Beverly Hills?
Compare family medicine physicians in the Beverly Hills area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
3,133
Per 100K population
31.8
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Azizollahi is a clinical cardiology specialist, with above-average Medicare volume (top 3% in CA), with low-engagement industry engagement in the top 5% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Azizollahi experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Azizollahi performed 978 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Azizollahi receive payments from pharmaceutical companies?
Yes. Dr. Azizollahi received a total of $8,068 from 55 companies across 397 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Azizollahi's costs compare to other family medicine physicians in Beverly Hills?
Dr. Azizollahi's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Azizollahi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →